BioSpace News Archive

Increasing Advancement, and Novel Innovations in the Treatment are Expected to Drive Hairy Cell Leukemia Market Revenue Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Hairy Cell Leukemia Market – Forecast to 2030,’ thoroughly examines the Hairy Cell Leukemia industry to provide essential data & information for the targeted readers.

September 21, 2022
·
6 min read
Pharm Country

Researchers Receive $4.2M Grant to Improve PrEP Access and Prevent New HIV Infections

Bronx county has the country’s fifth-highest rate of HIV diagnosis—but the lowest rate in New York State for use of HIV pre-exposure prophylaxis (PrEP), medications that are extremely effective in preventing HIV infection.

September 21, 2022
·
5 min read
Increasing Prevalence of Disease is Expected to Drive Stills Market Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Stills Market – Forecast to 2030,’ thoroughly examines the Stills industry to provide essential data & information for the targeted readers.

September 21, 2022
·
5 min read
Minimal Residual Disease Market Size Worth USD 4,138.5 Million in 2030 | Emergen Research

The global Minimal Residual Disease (MRD) market size was USD 1,095.3 Million in 2021 and is expected to register a revenue CAGR of 16.04% during the forecast period, according to the latest analysis by Emergen Research.

September 21, 2022
·
6 min read
Pharm Country

Frontage Announces Opening of Custom-Built State-of-the-Art Laboratory Facility in Hayward, CA

Frontage Laboratories, Inc. is pleased to announce the opening of a custom-built 19,000 square foot laboratory located at 3801 Bay Center Place, Hayward California.

September 21, 2022
·
2 min read
Global Tissue Engineering Market Expected To Grow at a CAGR of 20% During Forecast Period | Emergen Research

The tissue engineering market is expected to grow at a CAGR of around 20% during the forecast period.

September 21, 2022
·
6 min read
Guerbet: 2022 half-year results

Villepinte, Wednesday, September 21, 2022: Guerbet, a global specialist in contrast agents and solutions for medical imaging, is announcing its consolidated results for the first half of 2022.

September 21, 2022
·
9 min read
Business

Ellison Institute Welcomes Dr. Reva Basho as new Director of the Women’s Cancer Program

The Lawrence J. Ellison Institute for Transformative Medicine announced the appointment of Dr. Reva Basho as the Institute’s new Director of the Women’s Cancer Program.

September 21, 2022
·
4 min read
Drug Development

Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug’s Best-in-Class Potential

Ascentage Pharma (6855.HK) announced that the results from a Phase I and Phase II study of olverembatinib (HQP1351) for the treatment of chronic myeloid leukemia (CML) have recently been published in the renowned oncology journal, the Journal of Hematology & Oncology (JHO), further demonstrating the durable efficacy and safety of olverembatinib in patients with CML.

September 21, 2022
·
14 min read
Increasing Prevalence of the Breast Cancer Across the Globe Ductal Carcinoma in Situ Market Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Ductal Carcinoma in Situ Market – Forecast to 2030,’ thoroughly examines the Ductal Carcinoma in Situ industry to provide essential data & information for the targeted readers.

September 21, 2022
·
6 min read